Laguna Blends Reports 100% Improvement in Skin Appearance Following 14 Days of Clinical Tests of CBD CannaCeuticals Facial Serum - Video News Alert on InvestmentPitch.com

July 14, 2016 11:40 AM EDT | Source: InvestmentPitch Media

Vancouver, British Columbia--(Newsfile Corp. - July 14, 2016) - Network marketing company Laguna Blends Inc. (CSE: LAG) (FSE: LB6A.F) (OTC Pink: LAGBF) reported highlights of the clinical data provided by CannaCeuticals regarding a new line of skin care products. Laguna recently announced a non-binding letter of intent, and is currently negotiating a definitive agreement, to acquire the exclusive license brand name of this Swiss developed CBD skin care line of products. Cannabidiol or CBD, is a non-psychoactive cannabinoid found in hemp plants.

InvestmentPitch.com has produced a "video news alert" which discusses this news. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Laguna" in the search box. It is also available on YouTube (click here).



Cannot view this video? Visit:
http://www.investmentpitch.com/video/0_vk4mhtrd/Laguna-Blends-CSE-LAG-reported-highlights-of-clinical-data-provided-by-CannaCeuticals

During the clinical trials, conducted by BioScreen Testing Services, a third party FDA approved lab located in the USA, 21 female test subjects between the ages of 35 and 65 used the Facial Serum. 100% of the test subjects noticed an overall improvement of their skin appearance within 14 days, with approximately 81% saying they would purchase the Canna Serum product if it was available for sale.

Upon closing of the proposed transaction, Laguna will purchase the entire existing Canna inventory for US$250,000 payable over 6 months, and will pay a license fee of US$100,000, payable in shares of Laguna. Laguna will receive an exclusive Canadian and US license to the Canna products for a period of 2 years. Laguna will also receive the license and marketing rights to sell the Canna products in Asia, Europe and Mexico, conditional upon Laguna entering those markets, and providing Canna has been approved in those markets.

Ray Grimm Jr., President, stated: "Obviously when you receive a 100% improvement with a product you have a home run type of product with proven science and clinical data. Laguna is ecstatic to be in negotiations to acquire the Cannaceuticals brand name and product line. Management believes that this proposed acquisition will immediately establish Laguna as a player in the skin care category. In addition, since the Canna line of eight products contain CBD's, we will offer something very unique to the market. Skin care is one of the largest direct sales categories and woman are amongst the largest segment of the direct sales market. Assuming we are able to acquire rights to these products under a definitive agreement, we anticipate that this product category will position Laguna to be a player within the direct sales industry."

Swiss-based CannaCeuticals' CBD7 anti-aging skincare products incorporate CBD, a superior antioxidant and potential anti-inflammatory, both of which are significant in anti-aging.

According to MarketResearch.com, the global skin care market is a US$121 billion industry, with anti-aging products the largest growth area within the skin care market.

Laguna generates retail sales through independent affiliates, using an innovative 3D technology Laguna World platform (www.lagunaworld.com) for recruiting, training and generating sales.

Laguna currently has two products, the first being a hemp protein coffee called Caffé, an instant, "just add water" hot coffee beverage, infused with whey and hemp protein and natural flavours, containing 20% protein in every serving. The second, a hemp protein functional beverage called Pro369, currently is available in four flavours, chocolate banana, mixed berry, vanilla caramel, and tropical powder. Hemp is a good source of protein, omega 3, 6 and 9 fatty acids, magnesium, zinc, iron, and dietary fibre, and therefore has been receiving increasing focus on its potential use in health foods and functional foods.

Fundamental Research has a $0.45 target price on Laguna, which is currently trading at $0.28.

For more information, please visit the company's website www.lagunablends.com, or contact QualityStocks at 480-374-1336 or email ir@lagunablends.com.

About InvestmentPitch Media

InvestmentPitch Media is arguably the largest producer and distributer of video news content, primarily for small and mid-cap companies. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com

info